Charles River Laboratories International, Inc. vs Johnson & Johnson
CRL vs JNJ — side-by-side comparison from reported financials. CRL leads 4, JNJ leads 6 of 10 comparable metrics.
Charles River Laboratories International, Inc.
CRL · Healthcare
$301.79+1.27%Strained
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | CRL | JNJ |
|---|---|---|
| Price | $301.79 | $261.79 |
| Market cap | $14.4B | $631B |
| Revenue (TTM) | $4.00B | $97.9B |
| Revenue growth | +0.3% | +5.6% |
| Net margin | -6.0% | 21.5% |
| Free cash flow | $371M | $22.2B |
| Net cash (debt) | ($1.92B) | ($27.8B) |
| 1-year price return | +75.3% | +37.0% |
| P/E | 20.8 | 29.9 |
| P/E vs own history (cheap-side %) | 98% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -8% | 26% |
| CV checks passed | 5 of 10 | 10 of 10 |
| Employees | 19,700 | 140,800 |
Full résumé-style profiles: CRL CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.